LYEL
Lyell Immunopharma, Inc. Common Stock
$22.43
-0.73%
-0.16
Notify me if price changes either direction
Buy LYEL stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
477.1M
Enterprise value
219.7M
Trailing PE
-0.96545485819065
Forward PE
-28.333334
PEG Ratio
0.025846822975183
Enterprise to EBITDA
-1.191
Enterprise to revenue
5358.098
Price to book MRQ
1.3952397
Price to sales TTM
12331.855
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
41000
EBITDA
-184380992
Diluted EPS TTM
-22.75
Total Cash (MRQ)
319.6M
Current ratio (MRQ)
10.296
Operating Cash Flow (TTM)
-165015008
LYEL trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
